S.A. Mason’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6K | Hold |
640
| – | – | 0.01% | 328 |
|
|
2025
Q1 | $24.8K | Hold |
640
| – | – | 0.01% | 313 |
|
|
2024
Q4 | $21.6K | Hold |
640
| – | – | 0.01% | 312 |
|
|
2024
Q3 | $26.2K | Hold |
640
| – | – | 0.01% | 293 |
|
|
2024
Q2 | $24.6K | Hold |
640
| – | – | 0.01% | 287 |
|
|
2024
Q1 | $27.4K | Hold |
640
| – | – | 0.02% | 276 |
|
|
2023
Q4 | $23.7K | Hold |
640
| – | – | 0.02% | 275 |
|
|
2023
Q3 | $23.2K | Hold |
640
| – | – | 0.02% | 279 |
|
|
2023
Q2 | $22.8K | Hold |
640
| – | – | 0.02% | 282 |
|
|
2023
Q1 | $22.8K | Hold |
640
| – | – | 0.02% | 282 |
|
|
2022
Q4 | $22.5K | Hold |
640
| – | – | 0.02% | 284 |
|
|
2022
Q3 | $19K | Hold |
640
| – | – | 0.02% | 291 |
|
|
2022
Q2 | $35K | Hold |
640
| – | – | 0.03% | 275 |
|
|
2022
Q1 | $35K | Hold |
640
| – | – | 0.02% | 281 |
|
|
2021
Q4 | $35K | Hold |
640
| – | – | 0.02% | 279 |
|
|
2021
Q3 | $31K | Hold |
640
| – | – | 0.02% | 276 |
|
|
2021
Q2 | $32K | Hold |
640
| – | – | 0.02% | 269 |
|
|
2021
Q1 | $29K | Hold |
640
| – | – | 0.02% | 265 |
|
|
2020
Q4 | $29K | Hold |
640
| – | – | 0.02% | 255 |
|
|
2020
Q3 | $30K | Sell |
640
-8
| -1% | -$375 | 0.03% | 235 |
|
|
2020
Q2 | $33K | Hold |
648
| – | – | 0.03% | 233 |
|
|
2020
Q1 | $31K | Buy |
648
+8
| +1% | +$383 | 0.04% | 235 |
|
|
2019
Q4 | $38K | Buy |
+640
| New | +$38K | 0.04% | 246 |
|